This Saturday loads the diabetic group Oberndorf at one of its tenth anniversary at the Jubilee Celebration "Yesterday-Today-Tomorrow" in the local parish hall. During this event the general Erich Auer gives a talk on "The development of diabetes from the perspective of the family doctor", then the Diaetologinnen Monika Mayr, Susanne Kreische introduce the diabetes clinic at the hospital Oberndorf. Then the speakers at the visitors answer your questions about diabetes is available. Also for the physical well-being is taken care of. Admission is free for all. Voluntary donations are welcome and will be used by Oberndorfer Support for projects for children with diabetes.
Wednesday, October 7, 2009
Diabetes drug with side effects: Less Cancer
Drugs often have side effects, sometimes even serious side effects, and some even have been suspected to cause cancer. But in this case, a diabetes drug it is a different way. AOK-media mp Dusseldorf - Drugs often have side effects, sometimes even serious side effects, and some even have been suspected to cause cancer. But in this case, a diabetes drug it is a different way. AOK-media By Detlef Wilkens 2. Oct 2009, 16:23 Drugs often have side effects, sometimes even serious side effects, and some even have been suspected to cause cancer. But in this case it is a different kind: the diabetes drug metformin reduced the likelihood of developing cancer. This report by researchers at the University of Dundee in Scotland in the journal 'Diabetes Care'. They assessed data from diabetic patients treated with metformin and compared them with a control group of diabetic patients taking metformin no. Because of the mode of action of the drug, the krebsunterdrückende effect is suspected for some time. The drug is contraindicated in patients with type 2 diabetes, the most frequently used drug. The Scottish researchers collected data from 4 085 diabetic patients who were treated from 1994 to 2003 for the first time with it. 297 patients developed cancer during the investigation period. These data were compared with 4 085 diabetics who were not treated with metformin. Of these, 474 persons became ill with cancer. Taking into account various factors was based on these data, a calculated probability of disease decreased by 37 percent. The researchers now hope to be able to better protect people with high risk of cancer by preventive administration of metformin. It could also be stopped, at least in patients with cancer tumor growth. But up to the use of metformin to prevent cancer, it is still a long way: Clinical studies in humans to confirm the action and, above all, to clarify the spectrum of adverse events, which is in non-diabetics not enough research. This could for example, increased intake of sugar from the blood in non-diabetic patients, lead to hypoglycemia, especially metformin also suppresses the formation of sugar in the liver. What are the effects of simulated by metformin, but not present sugar shortage in the cell would have non-diabetics, is also still unclear
Diabetes Type I: At 21 for the first time an ice lolly
The intention of this study was to show the change in dietary recommendations and thus also the dietary habits of Type I diabetes. Great influence on these changes was the introduction of intensive insulin therapy and glucose tolerance in diabetic diet. To test the validity of the hypothesis was conducted in the present study, a survey by twelve in-depth interviews with diabetes aged 17 to 36 years. The diabetes duration should be at least seven years, so that the interviewees were able to make a statement about the changes in the selection of products suitable for diabetics. 1. With the exception of four subjects participated in the form of glucose, all more or less complex carbohydrates to himself. Finally, they describe the difference of behavior with the conventional insulin therapy, which was invariably described as a major limitation. Also exclude those respondents, the glucose from their diet, can confirm that the intensified insulin therapy to bind to Clock and diet plan has largely lifted.
Step toward diabetes prevention
Researchers have identified mechanisms that may contribute to the fight against diabetes mellitus type 2. They conduct research on beta-cells from the pancreatic islets of the pancreas that are responsible for the production and secretion of insulin. Diabetes mellitus occurs when the beta cells fail to pancreatic islets. This oxidative stress, for which the beta cells are particularly sensitive plays an important role. As a result of excessive nutrient intake leads to an excess of insulin secretion and insulin resistance in the main target tissues of insulin, ie, liver, muscle and fat tissue. Insulin resistance and other nutrient intakes, forcing the beta cells that process more and more nutrients, and secrete more insulin - through the nutrient metabolism of oxidative stress arises, for example by endogenous hydrogen peroxide and nitric oxide. As a result of this overload either the insulin secretion of beta-cells diminishes or it comes to the death by programmed cell death, or apoptosis. When insulin resistance, not by the activity of beta-cells can be compensated, there is the disease of diabetes mellitus type 2. Beta-cells regulate antioxidant enzymes Researchers led by Professor Gisela Drews have developed in the in vitro experiments on beta-cells from mice, a method to protect these cells from oxidative stress and thus reduce their injury. The pharmacists have discovered how the beta cells through certain agents that can upregulate attack on certain ion channels, anti-oxidative enzymes and thus counteract the congestion. The so-treated cells are largely protected as compared to a control against the influence of oxidants such as hydrogen peroxide and nitric oxide. The protection consists of both in terms of insulin secretion as well as apoptosis. The identified active substances are used today to treat diabetes mellitus type 2. The findings of the Tübingen scientists now suggests that the active ingredients can also be used for the prevention of the disease. Before the results can lead the work on mouse cells to a therapeutic application, however, still require years of research. About eight percent of the population are currently suffering from diabetes mellitus type 2, can bring complications like heart attacks, strokes or kidney failure with it. In addition to genetic predisposition for the development of this form, a überkalorische diabetes diet, usually associated with physical inactivity is responsible. At increasingly younger ages of overweight and obesity occur, so that the average age is 55 years, declined in the last decade to now under 30 years.
EU Commission leaves-2-diabetes means "Onglyza" AstraZeneca's
AstraZeneca Plc and Bristol-Myers Squibb Co. have received for their diabetes-2-Medium "Onglyza" marketing approval from the European Commission. "The decision marks the European Commission an important milestone in the cooperation of both companies," said Bristol-Europe president Beatrice Cazala on Monday. The Diabetes 2 funding is the first jointly-developed drug that is marketed by both companies in Europe to market. In Europe suffer according to the company about 53 million people with diabetes. The U.S. Food and Drug Administration had already given its approval for Onglyza in July.
Tuesday, October 6, 2009
Diabetes in French Polynesia: a collective issue
The House of the diabetic, whose activities started in October 2003, several missions information and therapeutic care that are financed mainly by EPAP, a public administration for prevention. One of his goals is to help people with diabetes live better every day with their disease and to delay the complications it entails. But another facet of its activities, not least, is to establish a prevention program to the general public.
If Type 1 diabetes accounts for only 5% of the Polynesian population is mainly diabetes type 2, which concerned health authorities for several years, hence the creation of this structure paramedical there nearly six years .
20% of the population concerned The Polynesian genetic predisposition for this type of pathology, but also favorable environmental conditions (70% of the population is over-weight, a sedentary lifestyle due to increased urbanization ...) so require increased action and overall prevention. The health consequences are indeed obvious to the patient: risks of heart problems, blindness, amputation, required daily dialysis ...
The consequences for society are not less (sickness absence ...), and the financial impact of the management of these patients by the CPS (Caisse de Prevoyance Sociale) is far from negligible with present approximately 8,000 patients in care.These figures are however far from reflecting the reality with an estimated 20% of the population (approx. 50,000 people) people who may be affected more or less seriously by this disease, whose symptoms did not find that very progressively screened out. The leaders of the House of diet - which works in partnership with the health structures of the country but also with two associations that manage screening campaigns - have reminded the Minister the main work of the MDD to try to stop this scourge. Information and prevention must be strengtheneThis sets up throughout the year various activities of information for a healthier lifestyle (diet, physical activity ...) from patients who are sent by physicians. 1175 people with diabetes have benefited from an educational care since the creation of the MDD. And a hundred professionals have been trained to facilitate an educational network as well as in the Tahiti islands. Moreover, there are actions in companies to inform employees. Different 'Dating Polynesian fight against diabetes, "which are organized in Tahiti since 2006 have proved such a success (nearly 2,500 visitors in 2006), and a new animation of this type is planned for November. The means are far from being commensurate with the stakes and the minister, who acknowledged the quality and the investment by the small team of ten people, has expressed "wanting to fight" for the human and more substantial financial are made to serve the collective cause.
Ride for Diabetes
Ride for Diabetes Research in 2009 will be held for the first time in Laval, October 2 at Centropolis. Ride for Diabetes Research 2009 of the Research Foundation Juvenile Diabetes (JDRF) will be held October 2, between 11h and 14h at Centropolis Laval.
This event, staged for the first time in Laval, will bring together participants from sectors of finance, insurance, legal and accounting sciences from Laval in a friendly competition to raise funds for research Diabetes. Indeed, the organizing committee of the event, chaired by Yannik Laurin, National Bank, hope to raise $ 100 000. Ride for Diabetes Research @ $ p> is a stationary bike challenge in which teams of five cyclists pedaling for 40 minutes (eight minutes by bicycle) and compete to earn more miles and collect the most money. "This event will be hosted by singer Daniel Lavoie and will take place rain or shine. This activity is known to be fierce competition, but friendship that already exists in a dozen cities in Quebec, "said the assistant communications JDRF Dominique Quirion. "It will be easy enough for each team to exceed the goal by raising $ 625," she added. The type 1 diabetes, the most severe form of diabetes is an autoimmune disease that can not be avoided and that affects more than 55 000 Quebecers. The type 1 diabetes can occur at any time in his life, for no particular reason. This number increases by 3% to 5% per year, the largest increase occurring in children five to nine years. Canada is in sixth place in the world in terms of incidence of type 1 diabetes. The causes of this disease are still unknown. Founded in 1974 in Montreal, JDRF is the largest charitable organization and the most active in research on type 1 diabetes in the world. JDRF's mission is to find a cure for juvenile diabetes and its complications through the support of research. "We want people to have a better quality of life," said Dominique Quirion.
Physical inactivity and diabetes: the urgent need to link
The President of Diabetes Quebec, Serge Langlois, visited in Abitibi-Témiscamingue to raise awareness about the negative impact of modern lifestyle on health. An estimated 650 to 000 the number of diabetics in Quebec. Of these, approximately 200 000 are unaware of their condition. Diabetes is yet one of the leading causes of blindness, amputations and kidney failure, in addition to representing an important factor in cardiovascular disease. The latest figures dénombrent not less than 6,900 diabetics in Abitibi-Témiscamingue aged 20 and over. Aboriginal people are also at particular risk of developing the disease. Currently, 14% of area youth are obese, which gives the region the grim results of the third largest region of Quebec. However, obesity is an important factor in the onset of diabetes, whose prevalence is increasing among children and adolescents. For Serge Langlois, it is necessary to go back at our lifestyle. "The pace of modern life, often associated with progress, is very unhealthy," says he. "It is not necessary to run 10 miles every day to be healthy. Simply walk, while minimal attention to our diet, "says Langlois. In his lecture, President of Diabetes Québec has shown some examples, like a street photographed 100 years ago, and even today. Formerly, there were people everywhere in the picture, today, no one, but we see a multitude of cars. "I do not need to get rid of his car, I only say that it is easy to walk ten or fifteen minutes and you can choose smaller portions when feeding. Why take the biggest popcorn movie, "says he.
THE CREUSOT: Diabetes and heart and ... everyday life, Saturday at ALTO
Diabetes is becoming a worrying fact, related to the increase of overweight and physical inactivity. The Diabetes Prevention Network (2000 members) is to improve the overall care of people with diabetes, in partnership with health professionals and members of the municipalities. It offers interactive workshops proximity, diet, physical activity, groups of words ... etc ... Each year the General Assembly shall meet all its members and invites anyone interested in this disease to attend conferences information and learn from pharmaceutical innovations on the supervision and treatment of diabetes. The network teams and the Division of Diabetes will be available for visitors to discuss diet, blood pressure, footwear, and physical activity in attractive displays. This year, Dr. Louis Labbe diabetologist will address the theme "Diabetes and heart" and Dr Hermione Agopian diabetologist, "Diabetes and everyday life" with Sophie TRILLEAUD of the French Association of Diabetic which will be discussed difficulties in life every day: work, license, insurance ...
DIABEO: DIABETES MANAGED BY TELEMEDICINE
Today, telemedicine 'down the street, with the first Diabéo example, a tool for telemedicine to benefit patients with type 1 diabetes (IDDM absolute). An innovative device which meets all the requirements expected: it's tele-assistance, tele-surveillance, tele-consultation and tele-expertise.
Telemedicine is a concept developed to allow medical teams to provide them from city to city, region to region, to exchange information, discuss remote case of patients requiring a multidisciplinary approach to also allow physicians to require isolated Notice of a hospital specializing in one case, exchange and comment also images. It is obvious that the emergence of Internet has facilitated and accelerated this type of remote exchange.
It must be said that this example is striking because the initiatives are still few in the field of remote monitoring of a chronic condition. This initiative is a combination of work CERITD, Center for Studies and Research for Intensified Treatment of Diabetes, and Voluntis, creator of the software platform for e-health medpassport. They have developed an innovative device that meets the requirements expected: it's tele-assistance, tele-surveillance, tele-consultation and tele-expertise, the prefix "tele" takes its full meaning here, since it means (in Greek): Remote!
What was the problem? Answer: the constraints of chronic insulin therapy. Diabetes management is entrusted to the patient, ie multiple daily checks of blood glucose and multiple insulin injections. These constraints do not always facilitate the daily life and some people may feel isolated with their problems without support from their doctor.
Diabéo, created by clinicians and specialists in medical informatics, is a telemedicine solution for the monitoring of type 1 diabetes, presented by its designers as a real tool for therapeutic education (the concept evolving current) and d 'decision support, to empower the diabetes without that one has the impression that he must make do without the doctor. Diabéo is a software functional insulin downloaded on a phone-PDA and using the Internet channel through the operator Orange Healthcare. It is simple to use, which is essential if we want to extend and improve self-management of his illness by the patient. The transmission of data to the healthcare professional who follows the patient allows the constant monitoring of its biological control treatment, and can thus achieve a minimum ... teleconsultation for regular consultations assets are obviously necessary ... The study Télédiab 1 verified that Diabéo improves metabolic control in diabetic patients compared to a control group (not equipped). More importantly, this concept, its proponents say, can "reduce the distance between the practitioner and patient, to strengthen the management of patients, to optimize the working hours of nurses to meet increased demand for care without increase of resources. " This patient commits less spending by controlling blood glucose (lower frequency of complications), is supervised by a flexible, lightweight and above all do not feel the distance between him and his doctor, unless it is reluctant to computer ... and distance, which may exist in the psychology of these particular patients. The question obviously is, is it possible for type 2 diabetes? Certainly: Diabéo has opened prospects for a track that other diabetes, which requires, according to developers, complex treatment regimens by injection or pump, which is were the sole mode of treatment of type 1 but must be offered to Type 2 diabetes when oral (ADO) are no longer effective given the progression of type 2 to a similar stage of type 1. Law Hospital, health, patients and territories (HPST) includes an article on telemedicine. New information systems in the service of care and access to care, may contribute to the success of new issues of reforming the health system
Monday, October 5, 2009
Walk against Diabetes
The Society of poultry farmers, the town, several local associations and the European Center for the Study of Diabetes (CEED) organized on Sunday a large popular march against diabetes and medical research. Walking to say no to diabetes and to help researchers develop therapies. That's about the action day as they prepare for Sunday at Gerstheim. Organized on behalf of the European Center for the Study of Diabetes (CEED), this course will engage in fact, many volunteers from the community, very involved in the case. The free screenings for diabetes before and after the ride With the support of friendly blood donors, the Golden Age, music Concorde, ...
New data show that patients with type 2 diabetes who start therapy based insulin, combined with a single daily dose of NovoMix
New data show that patients with type 2 diabetes who start therapy based insulin, combined with a single daily dose of NovoMix ® 30 managed to reduce the HbA1c greater than treatment with insulin Glargine1 Data from a new study presented today at the annual meeting of the European Association for the Study of Diabetes (EASD) show that patients with type 2 diabetes initiating treatment with insulin combined a daily injection of NovoMix ® 30 (biphasic insulin aspart) are able to further reduce the HbA1cque patients starting with a daily injection of insulin glargine. The treatment with NovoMix ® 30 also resulted in blood glucose levels much lower after dinner and at bedtime, compared with those patients treated with insulin glargine.1
These new data from the study OnceMix in which 480 patients with type 2 diabetes inadequately controlled by oral antidiabetic agents, participated in 15 countries. They were randomly selected for treatment based on a single daily injection of NovoMix ® 30 or insulin glargine. In total, 433 patients completed the study. The average reduction HbA1centre the baseline and the end of the study after 26 weeks was -1.41% with NovoMix ® 30 cons -1.25% with insulin glargine.1
"This study shows that NovoMix ® 30 is a particularly effective option for patients with type 2 diabetes to start insulin," said Professor Krzysztof Strojek Medical University of Silesia in Zabrze, Poland, the main author of the study. "An additional advantage of using a premixed insulin as the ® 30 from the beginning is that it is very easy to intensify the treatment as and progression of diabetes, which is both practical Patient and important in terms of long-term control of disease. " At the end of treatment, mean HbA1c was 7.08% for NovoMix ® 30 against 7.23% for insulin glargine. In the evaluation of postprandial glucose control, we observed much lower levels of plasma glucose with NovoMix ® 30 after dinner and at bedtime (NovoMix ® 30 - insulin glargine -0.52 mmol / l, 95% CI [-1.02, -0.03], p = 0.04) and (NovoMix ® 30 - insulin glargine = -0.78 mmol / l, 95% CI [-1.25, -0.31] , p <0.01) respectively.1 The incidence of hypoglycaemic episodes was very low with both treatments (6.5 episodes / year for NovoMix ® 30 against 4.8 episodes / year for insulin glargine, with three major hypoglycemic episodes in each group) and the dose final day was also low and similar with both NovoMix ® 30 with insulin glargine (0.32 + / -0.22 units / kg for NovoMix ® 30 against 0.29 + / -0.19 units / kg for insulin glargine) .1
No relevant difference a clinical point of view between the treatment groups were found in markers of cardiovascular risk, waist circumference, body mass or satisfaction of treatment.The study is an attempt OnceMix "treat-to-target" open multinational multicentre, randomized and parallel. This study was conducted in a wide range of patient populations in 15 countries and is the first direct study between NovoMix ® 30 once-daily insulin glargine and once-daily.
During the period of run-ins ", titration of glimepiride and metformin was performed, followed by randomization to a treatment period of 26 weeks. Of a total of 480 patients in total were randomly selected, 433 completed the trial and participated in the final analysis. NovoMix ® 30 (biphasic insulin aspart) is a modern premixed insulin, dual-action, indicated for the treatment of diabetes mellitus, which contains both the rapid-acting insulin (30%) and intermediate-acting insulin (70%). The compound-action rapid NovoMix ® 30 begins to exert an effect on the absorption of glucose between 0 and 10 minutes2, it can be taken just before meals, while human insulin must be administered 15-30 minutes before . The adverse side effects observed in patients treated with NovoMix ® 30 mainly doses and due to the pharmacological effect of insuline2Chez patients with type 2 diabetes, a meta-analysis showed that while the risk diurnal hypoglycemic episodes increased overall in patients treated with NovoMix ® 30, it was associated with reduced risk of nocturnal hypoglycemic episodes and overall major hypoglycaemia compared with human insulin bi-phasic 30.2
Novo Nordisk is a healthcare and the global leader in diabetes care. In addition, Novo Nordisk has a dominant position in the market for hemostasis management, growth hormone and hormones for treating menopausal disorders. Novo Nordisk manufactures and markets products and pharmaceutical services that make a difference for patients, the medical profession and society. Novo Nordisk, whose headquarters are located in Denmark, employs approximately 28,500 employees in 81 countries and sells its products in 179 countries. The B shares in Novo Nordisk are listed on stock exchanges in Copenhagen and London. Its ADRs are listed on the NYSE under the symbol "NVO"
1 Franek E, et al. Launching a single daily dose of NovoMix 30 compared with insulin glargine in patients with type 2 diabetes inadequately controlled with oral antidiabetic agents - a randomized controlled trial. 45th annual meeting of the European Association for the Study of Diabetes, Vienna, Austria, September 29 to October 2, 2009. Oral Presentation # 213
These new data from the study OnceMix in which 480 patients with type 2 diabetes inadequately controlled by oral antidiabetic agents, participated in 15 countries. They were randomly selected for treatment based on a single daily injection of NovoMix ® 30 or insulin glargine. In total, 433 patients completed the study. The average reduction HbA1centre the baseline and the end of the study after 26 weeks was -1.41% with NovoMix ® 30 cons -1.25% with insulin glargine.1
"This study shows that NovoMix ® 30 is a particularly effective option for patients with type 2 diabetes to start insulin," said Professor Krzysztof Strojek Medical University of Silesia in Zabrze, Poland, the main author of the study. "An additional advantage of using a premixed insulin as the ® 30 from the beginning is that it is very easy to intensify the treatment as and progression of diabetes, which is both practical Patient and important in terms of long-term control of disease. " At the end of treatment, mean HbA1c was 7.08% for NovoMix ® 30 against 7.23% for insulin glargine. In the evaluation of postprandial glucose control, we observed much lower levels of plasma glucose with NovoMix ® 30 after dinner and at bedtime (NovoMix ® 30 - insulin glargine -0.52 mmol / l, 95% CI [-1.02, -0.03], p = 0.04) and (NovoMix ® 30 - insulin glargine = -0.78 mmol / l, 95% CI [-1.25, -0.31] , p <0.01) respectively.1 The incidence of hypoglycaemic episodes was very low with both treatments (6.5 episodes / year for NovoMix ® 30 against 4.8 episodes / year for insulin glargine, with three major hypoglycemic episodes in each group) and the dose final day was also low and similar with both NovoMix ® 30 with insulin glargine (0.32 + / -0.22 units / kg for NovoMix ® 30 against 0.29 + / -0.19 units / kg for insulin glargine) .1
No relevant difference a clinical point of view between the treatment groups were found in markers of cardiovascular risk, waist circumference, body mass or satisfaction of treatment.The study is an attempt OnceMix "treat-to-target" open multinational multicentre, randomized and parallel. This study was conducted in a wide range of patient populations in 15 countries and is the first direct study between NovoMix ® 30 once-daily insulin glargine and once-daily.
During the period of run-ins ", titration of glimepiride and metformin was performed, followed by randomization to a treatment period of 26 weeks. Of a total of 480 patients in total were randomly selected, 433 completed the trial and participated in the final analysis. NovoMix ® 30 (biphasic insulin aspart) is a modern premixed insulin, dual-action, indicated for the treatment of diabetes mellitus, which contains both the rapid-acting insulin (30%) and intermediate-acting insulin (70%). The compound-action rapid NovoMix ® 30 begins to exert an effect on the absorption of glucose between 0 and 10 minutes2, it can be taken just before meals, while human insulin must be administered 15-30 minutes before . The adverse side effects observed in patients treated with NovoMix ® 30 mainly doses and due to the pharmacological effect of insuline2Chez patients with type 2 diabetes, a meta-analysis showed that while the risk diurnal hypoglycemic episodes increased overall in patients treated with NovoMix ® 30, it was associated with reduced risk of nocturnal hypoglycemic episodes and overall major hypoglycaemia compared with human insulin bi-phasic 30.2
Novo Nordisk is a healthcare and the global leader in diabetes care. In addition, Novo Nordisk has a dominant position in the market for hemostasis management, growth hormone and hormones for treating menopausal disorders. Novo Nordisk manufactures and markets products and pharmaceutical services that make a difference for patients, the medical profession and society. Novo Nordisk, whose headquarters are located in Denmark, employs approximately 28,500 employees in 81 countries and sells its products in 179 countries. The B shares in Novo Nordisk are listed on stock exchanges in Copenhagen and London. Its ADRs are listed on the NYSE under the symbol "NVO"
1 Franek E, et al. Launching a single daily dose of NovoMix 30 compared with insulin glargine in patients with type 2 diabetes inadequately controlled with oral antidiabetic agents - a randomized controlled trial. 45th annual meeting of the European Association for the Study of Diabetes, Vienna, Austria, September 29 to October 2, 2009. Oral Presentation # 213
62% more cases of diabetes
In seven years, the number of people over 20 years diagnosed with diabetes in Abitibi-Témiscamingue jumped dazzling. One in 14 is now suffering from this chronic disease.
This indicates that a document produced by the Agency for Health and Social Services for Abitibi-Témiscamingue. Diabetes is an incurable disease characterized by a high concentration of sugar in the blood. In 2006-2007, a total of 8243 persons were diagnosed diabetes, compared to 5075 in 1999-2000, an increase of 62% in seven years. For guidance, the increase was slightly higher in Quebec, where the number increased by 69% during the same period. The Agency believes this growth is attributable in part to an aging population. Indeed, the prevalence of diabetes increases significantly as people age. However, the aging population is not strong enough to explain by itself such an increase. The resurgence of cases reflects the actual rise of diabetes. Several factors may influence the onset of the disease, such as heredity, obesity, physical inactivity, a diet rich in fat and belonging to certain ethnic groups such as indigenous. The percentage of people with diabetes varies significantly within the region. Compared to the provincial average, rates are much lower in Témiscamingue. In contrast, the territory of the Center for Health and Social Services (CSSS) eskers show a higher rate than the provincial average. It is possible that the data are underestimated for CSSS Témiscamingue due to the use by some of the people of this area of health services in Ontario. Conversely, the fact that the CSSS eskers has almost never been a shortage of doctors in recent years can possibly explain better screening, so a higher rate of diabetes. Due to this continued rise in diabetes, promoting healthy diet and active lifestyle, two aspects that reduce the risk of disease is therefore important.
This indicates that a document produced by the Agency for Health and Social Services for Abitibi-Témiscamingue. Diabetes is an incurable disease characterized by a high concentration of sugar in the blood. In 2006-2007, a total of 8243 persons were diagnosed diabetes, compared to 5075 in 1999-2000, an increase of 62% in seven years. For guidance, the increase was slightly higher in Quebec, where the number increased by 69% during the same period. The Agency believes this growth is attributable in part to an aging population. Indeed, the prevalence of diabetes increases significantly as people age. However, the aging population is not strong enough to explain by itself such an increase. The resurgence of cases reflects the actual rise of diabetes. Several factors may influence the onset of the disease, such as heredity, obesity, physical inactivity, a diet rich in fat and belonging to certain ethnic groups such as indigenous. The percentage of people with diabetes varies significantly within the region. Compared to the provincial average, rates are much lower in Témiscamingue. In contrast, the territory of the Center for Health and Social Services (CSSS) eskers show a higher rate than the provincial average. It is possible that the data are underestimated for CSSS Témiscamingue due to the use by some of the people of this area of health services in Ontario. Conversely, the fact that the CSSS eskers has almost never been a shortage of doctors in recent years can possibly explain better screening, so a higher rate of diabetes. Due to this continued rise in diabetes, promoting healthy diet and active lifestyle, two aspects that reduce the risk of disease is therefore important.
Diabète.Une Information Day Saturday
An information day "Stop the complications of diabetes will be held Saturday from 10 am to 18 pm at the Palais du Grand Large, Saint-Malo (35). Gerard Raymond, national president of the French Association of diabetes, will moderate the day free and open to all
Healthcare in Canada Major advance against diabetes BUM
International researchers have just published in the journal Nature Genetics, the results of a study that could lead to a significant improvement in the treatment of type 2 diabetes. Researchers have identified a gene called substrate of insulin receptor 1 (SRI1). Unlike other gene discovered to date, SRI1 not involved in the decreased production of insulin, but it decreases the effects of insulin in muscle, liver and fat. It thus influences how the body responds to insulin in the bloodstream. Diabetes Type 2 primarily affects adults over 40 years. In 60% of cases, they are overweight, but there are important genetic factors that increase the risk of developing this disease. Diabetes type 2 has a body resistance to insulin, the hormone produced by the pancreas that allows cells to absorb glucose and convert it into energy.
Saturday, October 3, 2009
Prevalence of diabetes expected of atrial fibrillation, and the incidence among women
Atrial fibrillation is 44% more often and 38% more likely to develop diabetes, when it was present in an adult population - especially among women, according to data published recently.
The researchers assessed the prevalence and incidence of atrial fibrillation among patients with diabetes and 17,372 for the same amount of sex and age matched controls without diabetes type 2 diabetes included in a register of Kaiser Permanente Northwest. The researchers followed the patients without atrial fibrillation for comparison with the incidence of atrial fibrillation, while controlling known risk factors. The data showed that the prevalence of atrial fibrillation was significantly higher in patients with diabetes than in those without (3.6% vs 2.5%, P <.0001).
During an average follow-up of 7.2 years, patients with diabetes without atrial fibrillation initially developed atrial fibrillation with age and sex adjusted rate of 9.1 per 1000 person years against 6.6 per 1000 person-years among patients without diabetes. Diabetes is associated with an increased risk of 26% for atrial fibrillation in women after adjusting for other risk factors (HR = 1.26, 95% CI, 1,08-1,46). Diabetes is not a statistically significant risk factor in men.
Men have a higher prevalence of atrial fibrillation in all age groups irrespective of diabetes, but the difference in prevalence among people with diabetes vs without diabetes was higher among women. Atrial fibrillation is 30% more frequent among men aged 65 to 74 years with diabetes (7.9% vs 6.1%, P <.037), while the prevalence of atrial fibrillation was 61% higher among women with diabetes in the same age group (6.1% vs 3.8%, p =. 002). "These results have a potential impact on public health, especially women and stressed the need for further investigations of mechanical coupling between diabetes and atrial fibrillation," the researchers write.
The researchers assessed the prevalence and incidence of atrial fibrillation among patients with diabetes and 17,372 for the same amount of sex and age matched controls without diabetes type 2 diabetes included in a register of Kaiser Permanente Northwest. The researchers followed the patients without atrial fibrillation for comparison with the incidence of atrial fibrillation, while controlling known risk factors. The data showed that the prevalence of atrial fibrillation was significantly higher in patients with diabetes than in those without (3.6% vs 2.5%, P <.0001).
During an average follow-up of 7.2 years, patients with diabetes without atrial fibrillation initially developed atrial fibrillation with age and sex adjusted rate of 9.1 per 1000 person years against 6.6 per 1000 person-years among patients without diabetes. Diabetes is associated with an increased risk of 26% for atrial fibrillation in women after adjusting for other risk factors (HR = 1.26, 95% CI, 1,08-1,46). Diabetes is not a statistically significant risk factor in men.
Men have a higher prevalence of atrial fibrillation in all age groups irrespective of diabetes, but the difference in prevalence among people with diabetes vs without diabetes was higher among women. Atrial fibrillation is 30% more frequent among men aged 65 to 74 years with diabetes (7.9% vs 6.1%, P <.037), while the prevalence of atrial fibrillation was 61% higher among women with diabetes in the same age group (6.1% vs 3.8%, p =. 002). "These results have a potential impact on public health, especially women and stressed the need for further investigations of mechanical coupling between diabetes and atrial fibrillation," the researchers write.
School rules eased Diabetes
Parents of students with diabetes are cheering Governor Jon Corzine signed, a bill that allows teachers to administer plans of glucagon to diabetic students and allow children to treat the disease in the class.
For TimesAllison Klei, 10-year-old Lawrenceville, holds a glucagon emergency kit she carries with her to have her treated diabetes should she become unconscious.
The measure was opposed by the state union of teachers and the School Nurses Association, whose president said yesterday that she still believes the new law conflicts with the legal obligations of nurses not medical delegate responsibilities.
Corzine on Thursday signed the bill and several other bills unrelated. It was good news for parents like Howard Effron of Barnegat, who had been frustrated by the delay of the Governor to sign the measure after it was passed by both houses of the legislature in June
"It's just a good thing. It will make life much easier," said Effron, whose 14-year-old son has diabetes type I. Under the new law, teachers in May voluntarily accept to be trained to give injections of glucagon, which are used in rare cases to boost students with diabetes who fell unconscious because of low blood sugar levels.
Some schools have only allowed nurses to give shots, which in some cases made it impossible for students to participate in school programs and sporting events where a nurse was not present.
"This new law will give parents who have children with diabetes greater peace of mind knowing that if something should happen to their children while at school, they will be supported by trained people who know what to do, "state Sen. Shirley Turner, D-Lawrence, said yesterday.
The law also requires school nurses to develop plans of care for diabetic children and allows students to test their blood sugar and use insulin pumps in the classroom.
Just this week, met with key Effron his son, who would be trained in glucagon injections himself but was advised not to school by lawyers who were concerned about liability issues, according Effron. The law contains a disclaimer which should make it easier to overcome these objections, although he said he could still face obstacles with the school staff. "We have to see what the nurse said," he said. "It was pretty adamantly against it. Who knows what the union will tell him to do."
Marie Peppas, a school nurse in Long Valley and the President of the State of New Jersey Association of School Nurses, said yesterday that the new law will not change because it conflicts with the legal obligations of nurses. "The law on nursing practice, and our license does not allow us to delegate to non-medical staff," Peppas said. "It does not really matter what Bill says. We have our permit to answer.
Over the last 10 years, schools in New Jersey have had to call ambulances only a few times to administer glucagon, in the absence of a school nurse, "she said. "We want all students to be safe and healthy school and we will do whatever it takes to get there," she said. "We are already that this happens. We don ' have no need for the bill. "
Peppas said board of state nursing is to review the new law. Council Regulation Committee will discuss at a meeting October 20, a council employee said. Turner said lawyers for the governor to review invoices to ensure they pass legal muster, and she noted that doctors and parents have voted for the bill that he received legislative approval . "They certainly would not defend something that is detrimental to their patients and children," she said.
For TimesAllison Klei, 10-year-old Lawrenceville, holds a glucagon emergency kit she carries with her to have her treated diabetes should she become unconscious.
The measure was opposed by the state union of teachers and the School Nurses Association, whose president said yesterday that she still believes the new law conflicts with the legal obligations of nurses not medical delegate responsibilities.
Corzine on Thursday signed the bill and several other bills unrelated. It was good news for parents like Howard Effron of Barnegat, who had been frustrated by the delay of the Governor to sign the measure after it was passed by both houses of the legislature in June
"It's just a good thing. It will make life much easier," said Effron, whose 14-year-old son has diabetes type I. Under the new law, teachers in May voluntarily accept to be trained to give injections of glucagon, which are used in rare cases to boost students with diabetes who fell unconscious because of low blood sugar levels.
Some schools have only allowed nurses to give shots, which in some cases made it impossible for students to participate in school programs and sporting events where a nurse was not present.
"This new law will give parents who have children with diabetes greater peace of mind knowing that if something should happen to their children while at school, they will be supported by trained people who know what to do, "state Sen. Shirley Turner, D-Lawrence, said yesterday.
The law also requires school nurses to develop plans of care for diabetic children and allows students to test their blood sugar and use insulin pumps in the classroom.
Just this week, met with key Effron his son, who would be trained in glucagon injections himself but was advised not to school by lawyers who were concerned about liability issues, according Effron. The law contains a disclaimer which should make it easier to overcome these objections, although he said he could still face obstacles with the school staff. "We have to see what the nurse said," he said. "It was pretty adamantly against it. Who knows what the union will tell him to do."
Marie Peppas, a school nurse in Long Valley and the President of the State of New Jersey Association of School Nurses, said yesterday that the new law will not change because it conflicts with the legal obligations of nurses. "The law on nursing practice, and our license does not allow us to delegate to non-medical staff," Peppas said. "It does not really matter what Bill says. We have our permit to answer.
Over the last 10 years, schools in New Jersey have had to call ambulances only a few times to administer glucagon, in the absence of a school nurse, "she said. "We want all students to be safe and healthy school and we will do whatever it takes to get there," she said. "We are already that this happens. We don ' have no need for the bill. "
Peppas said board of state nursing is to review the new law. Council Regulation Committee will discuss at a meeting October 20, a council employee said. Turner said lawyers for the governor to review invoices to ensure they pass legal muster, and she noted that doctors and parents have voted for the bill that he received legislative approval . "They certainly would not defend something that is detrimental to their patients and children," she said.
Lions bus trip with Diabetes Expo
Lions International District 5M9 offers bus trip 5th annual Diabetes Expo of the American Diabetes Association's 2009, Saturday, October 24th at the Minneapolis Convention Center 9-3 places are limited, please book your place early .
Transportation and admission to the Expo are free to Lions District sponsored the bus.
Drop are the bus garage Frazee at 4:40 am, Kmart, Detroit Lakes to 5 pm Pamid in Perham at 5:30 am, Wadena Inn & Grill in Wadena at 6 hours and the hospital Staples Staples to 6 pm 30 hours of return will be approximately 6-6:30 pm The Expo is one of the largest diabetes programs in the country. You'll learn how to thrive with diabetes with advice and demonstrations on how to eat healthier, be more active, monitor your blood sugar, taking care of your feet and eyes and much more.
At Expo, you can participate in free health checks, consult experts of diabetes learn the resources of diabetes on the American Association. You can reach the kitchen fun and fitness demonstrations, learning more about diabetes products to newer technology, resources and treatment. There are also educational workshops you can attend, and you can also meet other people with diabetes. The first speaker is Jennifer Burden, MS, and she will speak on the emotions of living with diabetes. John Bantle, MD, University of Minnesota Medical Center, Fairview, will discuss surgery as an option for type 2 diabetes and work about to resolve type 2 diabetes.
Harold Katz, MD of Allina Hospitals & Clinics, will speak on diabetes management in the Times in financial difficulty. A debate, led by Sayeed Ikramuddin, MD, is on Weight Loss Surgery - promising option for treating type 2 diabetes. Amy Tuchenhagen discuss Keeping Kids Safe with diabetes, and Ted Prevatt - a man with type 2 diabetes - will give his testimony insulin Myths and Realities.
Transportation and admission to the Expo are free to Lions District sponsored the bus.
Drop are the bus garage Frazee at 4:40 am, Kmart, Detroit Lakes to 5 pm Pamid in Perham at 5:30 am, Wadena Inn & Grill in Wadena at 6 hours and the hospital Staples Staples to 6 pm 30 hours of return will be approximately 6-6:30 pm The Expo is one of the largest diabetes programs in the country. You'll learn how to thrive with diabetes with advice and demonstrations on how to eat healthier, be more active, monitor your blood sugar, taking care of your feet and eyes and much more.
At Expo, you can participate in free health checks, consult experts of diabetes learn the resources of diabetes on the American Association. You can reach the kitchen fun and fitness demonstrations, learning more about diabetes products to newer technology, resources and treatment. There are also educational workshops you can attend, and you can also meet other people with diabetes. The first speaker is Jennifer Burden, MS, and she will speak on the emotions of living with diabetes. John Bantle, MD, University of Minnesota Medical Center, Fairview, will discuss surgery as an option for type 2 diabetes and work about to resolve type 2 diabetes.
Harold Katz, MD of Allina Hospitals & Clinics, will speak on diabetes management in the Times in financial difficulty. A debate, led by Sayeed Ikramuddin, MD, is on Weight Loss Surgery - promising option for treating type 2 diabetes. Amy Tuchenhagen discuss Keeping Kids Safe with diabetes, and Ted Prevatt - a man with type 2 diabetes - will give his testimony insulin Myths and Realities.
Winter 2010 Ride for Diabetes - Radical Roads
Crazy man Mike Cole rode across Canada last year to heighten awareness of Diabetes and to raise funds for Diabetes research and a cure.
He braved icy roads, blowing snow and minus 67 degree Celsius temperatures to accomplish the 2009 ride and he did that ride Largely without sponsors or funding. (Click on the above link to view one of many videos from the 2009 ride)
This year, Michael is looking for assistance. He needs sponsors and we are reaching out to the motorcycle community to find him that support. Your help is needed to help stop the Diabetes Epidemic.
Here are some facts about Diabetes and the preliminary information on the 2010 ride:
From the Canadian Diabetes Association: The personal costs of diabetes may include a reduced quality of life and the Increased likelihood of complications such as heart disease, stroke, kidney disease, blindness, amputation and erectile dysfunction.
* Approximately 80% of people with diabetes will die as a result of heart disease or stroke.
* Diabetes is a contributing factor in the deaths of approximately 41.500 Canadians each year.
* Canadian adults with diabetes are twice as Likely to die prematurely, compared to people without diabetes.
* Life expectancy for people with type 1 diabetes may be shortened by as much as 15 years. Life expectancy for people with type 2 diabetes may be shortened by 5 to 10 years.
The financial burden of diabetes and its complications is enormous.
* People with diabetes incur medical costs that are two to three times higher than Those Without Diabetes. A person with diabetes can face direct costs for medication and supplies ranging from $ 1,000 to $ 15,000 a year.
* By 2010, it's estimated that diabetes will cost the Canadian health care system $ 15.6 billion a year and that number will rise to $ 19.2 billion by 2020.
He braved icy roads, blowing snow and minus 67 degree Celsius temperatures to accomplish the 2009 ride and he did that ride Largely without sponsors or funding. (Click on the above link to view one of many videos from the 2009 ride)
This year, Michael is looking for assistance. He needs sponsors and we are reaching out to the motorcycle community to find him that support. Your help is needed to help stop the Diabetes Epidemic.
Here are some facts about Diabetes and the preliminary information on the 2010 ride:
From the Canadian Diabetes Association: The personal costs of diabetes may include a reduced quality of life and the Increased likelihood of complications such as heart disease, stroke, kidney disease, blindness, amputation and erectile dysfunction.
* Approximately 80% of people with diabetes will die as a result of heart disease or stroke.
* Diabetes is a contributing factor in the deaths of approximately 41.500 Canadians each year.
* Canadian adults with diabetes are twice as Likely to die prematurely, compared to people without diabetes.
* Life expectancy for people with type 1 diabetes may be shortened by as much as 15 years. Life expectancy for people with type 2 diabetes may be shortened by 5 to 10 years.
The financial burden of diabetes and its complications is enormous.
* People with diabetes incur medical costs that are two to three times higher than Those Without Diabetes. A person with diabetes can face direct costs for medication and supplies ranging from $ 1,000 to $ 15,000 a year.
* By 2010, it's estimated that diabetes will cost the Canadian health care system $ 15.6 billion a year and that number will rise to $ 19.2 billion by 2020.
Successful cell therapy of diabetes
The aim of cell therapy is to restore a biological function deficient by the secretion of insulin. The technique used by researchers from Inserm and the medical teams of the CHU of Lille is to transplant in diabetic patients new pancreatic cells healthy. These cells are prepared in the laboratory from a donor pancreas and then administered to the patient by infusion into the vein of the liver, where they will relocate to secrete insulin and regulate blood sugar. For now, this new therapeutic approach remains restricted to forms of diabetes, the most unstable for which the prognosis is engaged. The need for a powerful anti-rejection treatment is, indeed, a major obstacle. This treatment requires careful monitoring for early identification and treatment of infectious complications and tumor (skin in particular) favored by lower immune defenses.
For now, the benefit seems to be largely offset the risks associated with transplantation. Only long-term monitoring of a larger number of patients will confirm that. A second obstacle to development on a larger scale cell transplantation is the limited availability of human pancreas from organ donors coordinated by the Agency for Biomedicine. Several recent studies still leave open the possibility to produce laboratory quantities of cells required, particularly from embryonic stem cells.
For now, the benefit seems to be largely offset the risks associated with transplantation. Only long-term monitoring of a larger number of patients will confirm that. A second obstacle to development on a larger scale cell transplantation is the limited availability of human pancreas from organ donors coordinated by the Agency for Biomedicine. Several recent studies still leave open the possibility to produce laboratory quantities of cells required, particularly from embryonic stem cells.
Farm Day Diabetes Walk In Bristol Are Rescheduled
A rainy weather forecast for today means the annual Family Farm Day activities and Step Out Walk fundraiser for diabetes research are being rescheduled.
The Bristol Historical Society and the Imagine Nation Museum Postponing are farm tours and activities at Roberts Orchards and Minor's Farm until Sunday. The event will feature a performance by the Bristol Choral Society at 1 pm at Roberts Orchards, and games and a series of pet-related activities will be held throughout the day. The farm will sell pumpkins, apple cider donuts, pies and more. Minor's Farm will also be open on Sunday to offer children's games, pumpkin picking and food for sale. Admission is free at both farms.The Step Out Walk to Fight Diabetes will be postponed until Friday. The fundraiser for the American Diabetes Association will be held at Lake Compounce, walkers are invited to arrive as early as 6 pm, with the walking starting at 7 pm All participants raising a minimum of $ 150 in pledges will receive a pass that will be good on Friday for all rides and the Haunted Graveyard.
The Bristol Historical Society and the Imagine Nation Museum Postponing are farm tours and activities at Roberts Orchards and Minor's Farm until Sunday. The event will feature a performance by the Bristol Choral Society at 1 pm at Roberts Orchards, and games and a series of pet-related activities will be held throughout the day. The farm will sell pumpkins, apple cider donuts, pies and more. Minor's Farm will also be open on Sunday to offer children's games, pumpkin picking and food for sale. Admission is free at both farms.The Step Out Walk to Fight Diabetes will be postponed until Friday. The fundraiser for the American Diabetes Association will be held at Lake Compounce, walkers are invited to arrive as early as 6 pm, with the walking starting at 7 pm All participants raising a minimum of $ 150 in pledges will receive a pass that will be good on Friday for all rides and the Haunted Graveyard.
How to travel with diabetes?
The Media Association will provide practical advice on travel management and diabetes in everyday life. That is the question that may arise many patients with this condition. In their answers, the association organizes Media Friday a day of testing and prevention. The theme of this 7th edition: Diabetes and travel. After nutrition, sports, the Media Association will attempt to provide advice on the theme of travel for people with diabetes and their entourages.
This structure, whose purpose is to promote education in the therapeutic department of Internal Medicine and Hospital, Day held Friday at the prevention hall Francois Mitterrand. Open to all, this event will offer fun and practical answers. "When people with diabetes, travel and fly, for example, it begs the question of jet lag. For the insulin intake is set at a fixed time. How this happens when one is 8 hours by plane and are in a country with 5 hours of jet lag? "Says Dr. Letrillard. Similarly to the diet to be followed by patients. "We need to find what would replace their food and the right amount," says the dietician from the association.
Given these complications, many patients no longer dare to travel or even have a social life as eating out. "When they know they go abroad, they can come see us at the hospital to adapt their protocol
Although wearing shoes in the mountains
Other practical aspects will be discussed as the choice of shoes for a living in the mountains or the issue of beach sand. In addition to these tips, visitors can get tested. But practitioners caution that "we will be there to reassure and dramatize if blood glucose is high. We then ask them to see their doctor and re-test fasting, because few will be at that day ", say doctors. Testing, which must be made as soon as possible. "The sooner we know, the better you can adjust the feeding behavior and medical treatment," conclude the association members. Other stalls offer finally taking blood pressure or present the new laboratories. And to give the best tools to better prepare his case in future vacations.
This structure, whose purpose is to promote education in the therapeutic department of Internal Medicine and Hospital, Day held Friday at the prevention hall Francois Mitterrand. Open to all, this event will offer fun and practical answers. "When people with diabetes, travel and fly, for example, it begs the question of jet lag. For the insulin intake is set at a fixed time. How this happens when one is 8 hours by plane and are in a country with 5 hours of jet lag? "Says Dr. Letrillard. Similarly to the diet to be followed by patients. "We need to find what would replace their food and the right amount," says the dietician from the association.
Given these complications, many patients no longer dare to travel or even have a social life as eating out. "When they know they go abroad, they can come see us at the hospital to adapt their protocol
Although wearing shoes in the mountains
Other practical aspects will be discussed as the choice of shoes for a living in the mountains or the issue of beach sand. In addition to these tips, visitors can get tested. But practitioners caution that "we will be there to reassure and dramatize if blood glucose is high. We then ask them to see their doctor and re-test fasting, because few will be at that day ", say doctors. Testing, which must be made as soon as possible. "The sooner we know, the better you can adjust the feeding behavior and medical treatment," conclude the association members. Other stalls offer finally taking blood pressure or present the new laboratories. And to give the best tools to better prepare his case in future vacations.
Friday, October 2, 2009
EU launches campaign for healthy eating among students
Children in Europe are to eat healthier and drink. That is to meet EU Agriculture Commissioner Mariann Fischer Boel, with a new campaign. "When you see how many obese children there, it is clear that we must act now," said the Dane on Monday in Brussels.
Approximately 22 million children in the EU suffer from obesity, according to the Authority, five million of them even to obesity. The total number of children in the EU was not disclosed.
The campaign complements the School Fruit and school milk program of the EU, said Fischer Boel. Thanks to the two initiatives, many children receive free fruit in schools across Europe, and milk. Therefore, the Commission giving a total of 145 million euros a year.
With things on the internet and information in seven EU countries - Germany is not there - the Commission wants to improve not only the eating habits of children, but also "still the same message," Fit does make fun "into school". A total of 18 000 children in 180 schools in Belgium, France, Great Britain, Ireland, Poland, Estonia and Lithuania are expected at the events.
Approximately 22 million children in the EU suffer from obesity, according to the Authority, five million of them even to obesity. The total number of children in the EU was not disclosed.
The campaign complements the School Fruit and school milk program of the EU, said Fischer Boel. Thanks to the two initiatives, many children receive free fruit in schools across Europe, and milk. Therefore, the Commission giving a total of 145 million euros a year.
With things on the internet and information in seven EU countries - Germany is not there - the Commission wants to improve not only the eating habits of children, but also "still the same message," Fit does make fun "into school". A total of 18 000 children in 180 schools in Belgium, France, Great Britain, Ireland, Poland, Estonia and Lithuania are expected at the events.
Diabetes pill may help you live longer and stay healthier
Miracle pill, a drug taken by diabetics may slow the aging process
Economic pill taken by millions of diabetics could be the secret to a long and healthy life.
The research suggests that metformin, which costs as little as 2p a tablet, could prolong human life. It may also be able to keep physically agile and mentally strong in old age was found. There are also signs that can help prevent people from putting on weight.
Professor Dominic Withers, from University College London, said the results suggest that it is possible to establish the anti-aging drugs. The researchers based their studies on worms, flies and dogs have shown very low calorie diets tend to live longer, healthier lives. To imitate the effect, without the need for design created mice diet can not make a key protein, called S6K1. Experiments have shown that blocking of S6K1 increases the energy levels of a sensor called AMPK. When you eat less, increase the levels of AMPK, and the body goes into a survival mode and slows the aging process. Metformin, which has been used safely for over 50 years to monitor the levels of blood sugar in age and obesity, diabetes related, was also found to increase levels of A* Britain must charge for the health and increase the retirement age to escape the debt crisis, says IMF
* Half of all children born in Great Britain live to 100, say researchers
* Could a pill to give you back the muscles of your youth?
* Can this little piece of plastic that looks ten years younger?
The tests found that mice of both sexes were healthy, but the effects were stronger than females, who also lived longer.
Their life expectancy has increased by an average of 20 percent. But some saw an increase of over 50 percent, reports the journal Science.
* Britain must charge for the health and increase the retirement age to escape the debt crisis, says IMF
* Half of all children born in Great Britain live to 100, say researchers
* Can a pill that the muscles of the back of your youth?
* Can this little piece of plastic that looks ten years younger?
In 'middle age', the creatures were leaner than normal mice of the same age and had stronger bones and better balance, strength and coordination. They were even more curious, suggesting that they were mentally sharper. It even appears that their immune system stronger and younger. It is expected that metformin can mimic other effects of blocking of S6K1.
Metformin
Elixir of life? Metformin, which costs as little as 2p a tablet, could prolong human life, scientists say
Diabetics that take as its ability to prolong life can be ignored by the effects of the disease.
Professor Withers drug plans to test the capacity anti-aging in mice and hope to begin the first human trials within five years.
These would be likely to be in obese people whose weight puts them at risk of diabetes and other conditions later in life.
The researchers also want to check the ability of the drug to prevent Alzheimer's disease.
Experiments with mice have given encouraging results so far
The success of evaluation: The mice tested lived longer and are healthier
Long history as a safe drug metformin means that I should go through the safety review as part of a new brand name drugs.
But there is probably 15 years ago is widely used to protect against diseases of aging.
Meanwhile, the teacher "strongly recommended healthy adults taking the drug, hoping to prolong his life.
Dr David Gems, said: "We suddenly much closer to the treatment of aging than we thought." We went from the first results in worm models to be "druggable" targets in mice."The next logical step is to see whether metformin can delay the aging process in humans
Economic pill taken by millions of diabetics could be the secret to a long and healthy life.
The research suggests that metformin, which costs as little as 2p a tablet, could prolong human life. It may also be able to keep physically agile and mentally strong in old age was found. There are also signs that can help prevent people from putting on weight.
Professor Dominic Withers, from University College London, said the results suggest that it is possible to establish the anti-aging drugs. The researchers based their studies on worms, flies and dogs have shown very low calorie diets tend to live longer, healthier lives. To imitate the effect, without the need for design created mice diet can not make a key protein, called S6K1. Experiments have shown that blocking of S6K1 increases the energy levels of a sensor called AMPK. When you eat less, increase the levels of AMPK, and the body goes into a survival mode and slows the aging process. Metformin, which has been used safely for over 50 years to monitor the levels of blood sugar in age and obesity, diabetes related, was also found to increase levels of A* Britain must charge for the health and increase the retirement age to escape the debt crisis, says IMF
* Half of all children born in Great Britain live to 100, say researchers
* Could a pill to give you back the muscles of your youth?
* Can this little piece of plastic that looks ten years younger?
The tests found that mice of both sexes were healthy, but the effects were stronger than females, who also lived longer.
Their life expectancy has increased by an average of 20 percent. But some saw an increase of over 50 percent, reports the journal Science.
* Britain must charge for the health and increase the retirement age to escape the debt crisis, says IMF
* Half of all children born in Great Britain live to 100, say researchers
* Can a pill that the muscles of the back of your youth?
* Can this little piece of plastic that looks ten years younger?
In 'middle age', the creatures were leaner than normal mice of the same age and had stronger bones and better balance, strength and coordination. They were even more curious, suggesting that they were mentally sharper. It even appears that their immune system stronger and younger. It is expected that metformin can mimic other effects of blocking of S6K1.
Metformin
Elixir of life? Metformin, which costs as little as 2p a tablet, could prolong human life, scientists say
Diabetics that take as its ability to prolong life can be ignored by the effects of the disease.
Professor Withers drug plans to test the capacity anti-aging in mice and hope to begin the first human trials within five years.
These would be likely to be in obese people whose weight puts them at risk of diabetes and other conditions later in life.
The researchers also want to check the ability of the drug to prevent Alzheimer's disease.
Experiments with mice have given encouraging results so far
The success of evaluation: The mice tested lived longer and are healthier
Long history as a safe drug metformin means that I should go through the safety review as part of a new brand name drugs.
But there is probably 15 years ago is widely used to protect against diseases of aging.
Meanwhile, the teacher "strongly recommended healthy adults taking the drug, hoping to prolong his life.
Dr David Gems, said: "We suddenly much closer to the treatment of aging than we thought." We went from the first results in worm models to be "druggable" targets in mice."The next logical step is to see whether metformin can delay the aging process in humans
Diabetes: Award to Corriere della Sera
A journalist of the Corriere della Sera Mario Pappagallo, is the winner of the Media Prize 2009 for communicating scientific and medical diabetes, along with Thomas Stuttaford, medical columnist of The Times honored for web communication and French colleague Brigitte Fanny-Cohen for television. Is the first time that recognition is given to Italy. The article is an award-winning "Focus" entitled "Emergency diabetes," and appeared in May 2008.
Below are the text of Article
Emergency diabetes
Three million patients, other 3 do not. A new case in the world every two seconds. All 'home bad habits
MILAN - A person in the world every two seconds and a half. A clock that does not miss a cruel blow. Are the new cases of type 2 diabetes, also called senile (but increasingly their thirties are affected), diagnosed on Earth. Duecentoquarantasei million patients in 2007, 380 million in 2025. But if you calculate the prediabetic (early signals with apparently normal blood sugar) you touch 555 million in 2007 and 789 million are "waiting" for 2025. A veritable epidemic "silent" because often asymptomatic. Only in Italy, compared to about 3 million diabetics (4.6%) as many are sick without knowing it: the 6 million total. And when it comes to diabetes, one must think of premises (overweight and obesity) and complications derived: in particular the blood vessels, the heart to the periphery. Stroke, gangrene, renal function with irreversible damage (fate: dialysis). Just under 4 million to the dead 'year in the world.
Health and social costs? Huge is an understatement, because this disease is no longer the rich countries, but also those in developing countries. In particular, the "new rich": China, India, Russia, Brazil. The Mediterranean diet, optimal preventive strategy, it seems banished from everyone, including the Italians who mark the records of children in oversize. Alberts today, tomorrow diabetics. Also because diabetogenic foods often cost much less than those "protected". And here is that expenditure induced diabetes rising. Calculations by the World Bank. In many countries has increased faster than the growth in GDP per capita and is robbing a growing part of the budgets of governments, employers, families and individuals. It is estimated that the treatment and strategies for the prevention of diabetes worldwide in 2007 was estimated at 400 billion dollars (260 billion) in 2025 and increased to more than $ 500 billion (330 billion euros).
Today in Italy each patient costs the NHS Euro 2589 's year. Beware, however: while in the low-income spending is almost entirely directed into the drugs that lower blood levels of glucose (sugar) in blood, in industrialized countries (like l 'Italy) 75% depends on the hospital costs for treating complications of the disease. The picture that helped to identify the danger has emerged thanks to the "Barometer of diabetes," the initiative of the Consultative Council of the Changing Diabetes Barometer, which since September 2007 has wanted to see clear on new cases, access to treatment, prevention and costs. The world. Politicians, the United Nations (resolution d 'alert in December 2006), doctors gathered in the' World Association (IDF), patients, studies such as Dawn, have begun to breed data. Forum in New York (21 nations intervened), the second in Rome to see what was done in twelve months. The overall picture of what is now the 'UN is the' World Health Organization (WHO) defines pandemic is traced by Jean-Claude Mbanya (University of Cameroon) President-elect of the 'IDF. Earthquakes wars infectious diseases? No.
If the 'man of the third millennium must tremble, l' alarm was raised by two opposite causes: hunger and diabetes. Two mines capable of blocking economic development, sink Budgets, unleashing new wars of class. Hungry poor, rich patients. Word 's order: prevention drastic information. The media seem inattentive: cancer, stroke and AIDS are most popular. Education in schools. Examples of little-used concepts: the rice is more diabetogenic pasta, sweeteners are more than a little sugar, hydrogenated fats are more oil or butter. How do they know? Few, if we consider the curve upward over the years who have a pancreas that can no longer produce the right amount of insulin. So? It should inject. There are alternative treatments. Before the pills hypoglycemic (lowering blood sugar, l 'last-born is also losing weight: it derives from' amphibious gila monster), then insulin subcutaneously. From learning to self-manage based on what you eat and how much physical activity is practiced. The more you're good (it is called good compensation of diabetes) have less damage over the years. The heart in the forefront. Another common place to be dispelled: Food is not always health ... eat well, yes. Early age.
In Italy one child in three is obese (1 in 4 is the European average) and therefore risk of getting diabetes already was young. Percentage growth than twenty 'years ago, when he was an overweight child in ten. To this figure must be added the children already obese and suffering from type 1 diabetes (13-14 thousand). In most cases this is type 1 diabetes (the autoimmune). "So far - says Renata Lorini, President of the Italian Society of Pediatric Endocrinology and diabetes - in Italy have been diagnosed in children only a hundred cases of type 2 diabetes, closely linked to the 'obesity'. L 'attention goes to the wrong lifestyle. Advice anti-diabetes: to walk more, for example, going to school on foot, eat healthier and drink less sugary drinks, including fruit juices; spend fewer hours in front of TV, computer and video games, making physical activity and sleep more . "The lack of sleep - adds Lorini - would increase the risk of insulin resistance." Insulin resistance means that it is not enough that produced the long run the whole system crashes. Last advice: a good breakfast in the morning. Good advice even for adults.
Must undergo periodic inspections: For obese every year, for others every 3 years. An important exam (just a drop of blood) is that of 'glycated hemoglobin: why our red blood cells in the long run it is as if' sweets'. It 'a clear signal even when the blood sugar is normal. Italian politicians have an 'idea, "the timely establishment of an agency that deals with all aspects related to diabetes and is able to coordinate all actors and all sectors of the' whole health education such as schools, mass communication, dissemination of prevention, better involvement of regional medical centers and further characterization of hospitalization and specialized care. " To launch the proposal is Senator (surgeon) Ignazio Marino. Now supported by another doctor senator, Antonio Tomassini. Short bipartisan proposal. Topics that will be included in the next two conferences in Turin, from 26 May, the Italian diabetologists who is Chairman Paolo Cavallo Perin, Rome, from early June, World event. L 'warning diabetes also involves ophthalmologists. All 'last Mido in Milan, was presented a survey conducted by Transitions Optical in 6 countries on a sample of 12,000 consumers: patients with diabetes know little or nothing about the effects on vision. With low propensity for surveys. Diseases? Retinopathy, cataracts, macular degeneration and an 'increased sensitivity to the harmful ultraviolet rays. All preventable.
Below are the text of Article
Emergency diabetes
Three million patients, other 3 do not. A new case in the world every two seconds. All 'home bad habits
MILAN - A person in the world every two seconds and a half. A clock that does not miss a cruel blow. Are the new cases of type 2 diabetes, also called senile (but increasingly their thirties are affected), diagnosed on Earth. Duecentoquarantasei million patients in 2007, 380 million in 2025. But if you calculate the prediabetic (early signals with apparently normal blood sugar) you touch 555 million in 2007 and 789 million are "waiting" for 2025. A veritable epidemic "silent" because often asymptomatic. Only in Italy, compared to about 3 million diabetics (4.6%) as many are sick without knowing it: the 6 million total. And when it comes to diabetes, one must think of premises (overweight and obesity) and complications derived: in particular the blood vessels, the heart to the periphery. Stroke, gangrene, renal function with irreversible damage (fate: dialysis). Just under 4 million to the dead 'year in the world.
Health and social costs? Huge is an understatement, because this disease is no longer the rich countries, but also those in developing countries. In particular, the "new rich": China, India, Russia, Brazil. The Mediterranean diet, optimal preventive strategy, it seems banished from everyone, including the Italians who mark the records of children in oversize. Alberts today, tomorrow diabetics. Also because diabetogenic foods often cost much less than those "protected". And here is that expenditure induced diabetes rising. Calculations by the World Bank. In many countries has increased faster than the growth in GDP per capita and is robbing a growing part of the budgets of governments, employers, families and individuals. It is estimated that the treatment and strategies for the prevention of diabetes worldwide in 2007 was estimated at 400 billion dollars (260 billion) in 2025 and increased to more than $ 500 billion (330 billion euros).
Today in Italy each patient costs the NHS Euro 2589 's year. Beware, however: while in the low-income spending is almost entirely directed into the drugs that lower blood levels of glucose (sugar) in blood, in industrialized countries (like l 'Italy) 75% depends on the hospital costs for treating complications of the disease. The picture that helped to identify the danger has emerged thanks to the "Barometer of diabetes," the initiative of the Consultative Council of the Changing Diabetes Barometer, which since September 2007 has wanted to see clear on new cases, access to treatment, prevention and costs. The world. Politicians, the United Nations (resolution d 'alert in December 2006), doctors gathered in the' World Association (IDF), patients, studies such as Dawn, have begun to breed data. Forum in New York (21 nations intervened), the second in Rome to see what was done in twelve months. The overall picture of what is now the 'UN is the' World Health Organization (WHO) defines pandemic is traced by Jean-Claude Mbanya (University of Cameroon) President-elect of the 'IDF. Earthquakes wars infectious diseases? No.
If the 'man of the third millennium must tremble, l' alarm was raised by two opposite causes: hunger and diabetes. Two mines capable of blocking economic development, sink Budgets, unleashing new wars of class. Hungry poor, rich patients. Word 's order: prevention drastic information. The media seem inattentive: cancer, stroke and AIDS are most popular. Education in schools. Examples of little-used concepts: the rice is more diabetogenic pasta, sweeteners are more than a little sugar, hydrogenated fats are more oil or butter. How do they know? Few, if we consider the curve upward over the years who have a pancreas that can no longer produce the right amount of insulin. So? It should inject. There are alternative treatments. Before the pills hypoglycemic (lowering blood sugar, l 'last-born is also losing weight: it derives from' amphibious gila monster), then insulin subcutaneously. From learning to self-manage based on what you eat and how much physical activity is practiced. The more you're good (it is called good compensation of diabetes) have less damage over the years. The heart in the forefront. Another common place to be dispelled: Food is not always health ... eat well, yes. Early age.
In Italy one child in three is obese (1 in 4 is the European average) and therefore risk of getting diabetes already was young. Percentage growth than twenty 'years ago, when he was an overweight child in ten. To this figure must be added the children already obese and suffering from type 1 diabetes (13-14 thousand). In most cases this is type 1 diabetes (the autoimmune). "So far - says Renata Lorini, President of the Italian Society of Pediatric Endocrinology and diabetes - in Italy have been diagnosed in children only a hundred cases of type 2 diabetes, closely linked to the 'obesity'. L 'attention goes to the wrong lifestyle. Advice anti-diabetes: to walk more, for example, going to school on foot, eat healthier and drink less sugary drinks, including fruit juices; spend fewer hours in front of TV, computer and video games, making physical activity and sleep more . "The lack of sleep - adds Lorini - would increase the risk of insulin resistance." Insulin resistance means that it is not enough that produced the long run the whole system crashes. Last advice: a good breakfast in the morning. Good advice even for adults.
Must undergo periodic inspections: For obese every year, for others every 3 years. An important exam (just a drop of blood) is that of 'glycated hemoglobin: why our red blood cells in the long run it is as if' sweets'. It 'a clear signal even when the blood sugar is normal. Italian politicians have an 'idea, "the timely establishment of an agency that deals with all aspects related to diabetes and is able to coordinate all actors and all sectors of the' whole health education such as schools, mass communication, dissemination of prevention, better involvement of regional medical centers and further characterization of hospitalization and specialized care. " To launch the proposal is Senator (surgeon) Ignazio Marino. Now supported by another doctor senator, Antonio Tomassini. Short bipartisan proposal. Topics that will be included in the next two conferences in Turin, from 26 May, the Italian diabetologists who is Chairman Paolo Cavallo Perin, Rome, from early June, World event. L 'warning diabetes also involves ophthalmologists. All 'last Mido in Milan, was presented a survey conducted by Transitions Optical in 6 countries on a sample of 12,000 consumers: patients with diabetes know little or nothing about the effects on vision. With low propensity for surveys. Diseases? Retinopathy, cataracts, macular degeneration and an 'increased sensitivity to the harmful ultraviolet rays. All preventable.
HEALTH: IN THE PIEDMONT OF DIABETES CAMPAIGN good compensation
Arrive in Piedmont Unita 'Mobile in the BCD to inform and sensitize citizens on the importance of "good compensation of diabetes and how to control the disease. Saturday, September 19th at Chivasso, Monday '21 September in Turin and Wednesday' 23 September to Novara doctors diabetologists AMD (Association of Diabetes Specialists) and SID (Societa 'Italian di Diabetologia) and nurses of OSDI (Italian Health Care Workers of Diabetology) almost for the public analysis of blood glucose and, for the first time, glycated hemoglobin, crucial parameter for controlling diabetes over time. The stages are held in the "National Campaign BCD - Information. Allies. Protected. "Which was launched in 2008 making stops in 18 provincial capitals throughout the peninsula. The initiative 'made possible thanks to the contribution of Sanofi-aventis, and it' promoted by the IDF (International Diabetes Federation) under the patronage of the Ministry of Health. The choice of test is not 'random: the set of two values is today the best way' to assert that effective diabetes and 'controlled. A lot of the road still to be done to achieve this objective: according to data from a study by SIMG in 2007, 47 percent of people with diabetes has glycated hemoglobin values within the threshold considered by 7 percent, also in line with values the first data on the experiences recorded in the previous edition of the Campaign BCD. 'It is the key parameter to achieve good compensation of diabetes and controlling the disease in affected individuals. - Explains Professor Massimo Massi Benedetti, vice president IDF Global - good compensation of diabetes also means limiting the risk of occurrence of complications such as heart attacks and strokes, as well as damage to the arteries of the kidneys, legs and eyes. Just think, in this sense, today diabetes is not controlled, 'the leading cause of blindness' and amputations in eta 'adult'. Every person that will 'control sull'ambulatorio Mobile will' handed the booklet "BCD - the practical guide to learn how to control diabetes." "From Regional Registry Diabetes, it is estimated that in Piedmont are more than 205,000 people with diabetes, about 180,000 of those affected by diabetes" type 2 ". - Says Dr Anna Chiambretti, Regional President AMD-The main problem of diabetes and its complications are particularly increased cardiovascular risk. " "Information campaigns help an early detection and prevention - stresses Julius Titta, regional secretary FIMMG - E 'need, however,' that of family medicine, the team diabetes care and all the figures, multidisciplinary and pluriprofessionali land in the management of person with diabetes, in a collaborative framework (integrated management of diabetes).
II National Day of the child with diabetes
A day dedicated to diabetes in childhood. E 'initiative launched for Saturday, September 26th by the Italian Society Pediatric Endocrinology and Diabetology (SIEDP) in all Italian centers of pediatric diabetology. In Locride to give kids the opportunity to attend numerous, it was decided to organize Friday, September 25th at the Conference Hall of the Hospital of Locri, starting from 16.30 a demonstration with the involvement of health workers, children with diabetes and their families, associations, citizens of Locride. An initiative to learn, discuss, reflect on a disease became common, but often ignored in environments where children and teenagers grow up and live with the objective of promoting knowledge and awareness about what it means to have diabetes at an early age. The program is a presentation by Dr. Francis Ma, the "network" pediatric diabetes care that has been defined and approved by resolution by the Management Company strategy based on the recommendations that the Regional Council voted in June last year. It is an integrated care pathways between hospital and territory, which calls for special attention to the role of family and school, or in contexts where the child lives with her illness. The Center for pediatric diabetology 's Operative Unit of Pediatrics' s Hospital of Locri in place following a significant number of babies, children and young people with diabetes from all over the territory of the Locri area. The Center of Locri had, recently, a significant official recognition by the Region of Calabria, the organization of regional network of care, including thirteen pediatric reference hospitals, has awarded Locri coordination functions. Will follow the awards ceremony by the Director-General Dr. Justin Ranieri, a boy with diabetes followed at the Center of Locri, who last August 23, the Olympic Stadium in Geneva, with the colors of blue jersey 's Italy, won the European final of the Junior Cup Diabetes 2009 (Class junior) football championship to seven, beating the team from Spain. After the Italian tournament selection, with the knockout matches played between Rome, Milan and the final in Coverciano, Italy, the very young has proved stronger than in other European teams. In eight countries joined the European tournament with over 200 boys: Austria, Denmark, France, Italy, Spain, Switzerland, Great Britain and 'International' composed of children from Hungary, Israel, Lithuania and Turkey. The real challenge for the young participants was to demonstrate to themselves and others that the condition of children with insulin dependent diabetes does not prevent sports and achieve important goals. All this thanks to the latest innovative therapies, such as integrated systems of insulin infusion and continuous monitoring of glucose. These systems, available for a short time in Italy, thanks to skilled expertise of Dr. Mariella Bruzzese, that deals with children with diabetes, are now used at the Center of Locri from some of the boys followed, and among these, there's just John, the "small Gattuso. Locride of that with his victory, gave great satisfaction to the whole of Calabria. Thanks, John. Operative Unit of Pediatrics
Thursday, October 1, 2009
UF Study: Tai chi can help people with diabetes, hypoglycemia
A regular Tai Chi exercise program can help people better control their diabetes, low blood sugar after a study by the University of Florida.
In a study of adults with type 2 diabetes, those who are in a supervised program of Tai Chi exercise on two days per week significantly improved the three days of practice at home for six months lowered fasting blood glucose, treatment of disease, diagnosed and improved their overall quality of life, including mental health, vitality and energy. "Tai Chi is really having an effect similar to other aerobic exercise on diabetic control. The distinction is, Tai Chi is a low-impact exercise, which means it is less stressful on bones, joints and muscles more severe physical effort, "said Beverly Roberts, Annabel Davis Jenks equipped professor at the School of Nursing at UF.
Roberts, with the song Rhayun, Chungnam National University, has studied the effects of Tai Chi in older Koreans. The research was featured in the June issue of the Journal of Alternative and Complementary Medicine. Approximately 23.6 million children suffer from adults in the United States, or 7.8 percent of the population, have diabetes. It occurs when the body does not produce or use insulin, a hormone that is needed to convert sugar required, starches and other food into energy for daily life. Risk factors include inactivity, obesity, physical, unhealthy diet, blood pressure and cholesterol can, history of gestational diabetes and increasing age, many of which are reduced by the movement.
"People assume it's for the continued benefit you, panting, sweating and red face after," said Roberts. "This May off people, especially older adults. However, we found that activities such as Tai Chi can be equally beneficial to improve health. " Tai Chi is an ancient Chinese martial art combines deep breathing and relaxation with slow, circular movements. This low-impact exercise will be changes in posture and develop, in coordination with arm movements.
Sixty-two participants, most Korean women who participated in the study. Half of the group at least 80 percent of the two sessions of one hour per week with three days of practice at home for six months, and the other half served as controls. These meetings had completed a significant improvement in glycemic control and reported higher vitality and energy.
"Those who have participated in sessions of tai chi actually lower blood sugar levels after three and six months," says Roberts. "They also had lower hemoglobin A1c, which means that better control of diabetes." In addition, levels of glucose in the blood improved, participants also reported significantly improved mental health. This was very encouraging, especially since people are less depressed in general, more active and independent, "says Roberts.
Tai Chi is also used for people with arthritis and disabilities to increase, thereby reducing the balance, muscle strength and mobility and the risk of falls. It is useful to examine its effects on other conditions, including the elderly, "said Roberts.
"Tai Chi is an excellent alternative for those who want the benefits of exercise on diabetes control, but not finished May physically demanding due to age, condition or injury," said Roberts. "Future studies could investigate whether tai chi could also benefit from diseases such as osteoporosis or heart disease." Since Tai Chi is an exercise that affects many parts of the body and also helps to relax the mind, it is likely to be participants in the exercise, said Paul Lam, a professor at the University of South Wales School of Public Health and Community Medicine and a practicing physician in Sydney, Australia.
"This study shows that Tai Chi can have a significant impact on management and treatment of diabetes - a health policy major and growing challenge for all Western countries," said Lam.
In a study of adults with type 2 diabetes, those who are in a supervised program of Tai Chi exercise on two days per week significantly improved the three days of practice at home for six months lowered fasting blood glucose, treatment of disease, diagnosed and improved their overall quality of life, including mental health, vitality and energy. "Tai Chi is really having an effect similar to other aerobic exercise on diabetic control. The distinction is, Tai Chi is a low-impact exercise, which means it is less stressful on bones, joints and muscles more severe physical effort, "said Beverly Roberts, Annabel Davis Jenks equipped professor at the School of Nursing at UF.
Roberts, with the song Rhayun, Chungnam National University, has studied the effects of Tai Chi in older Koreans. The research was featured in the June issue of the Journal of Alternative and Complementary Medicine. Approximately 23.6 million children suffer from adults in the United States, or 7.8 percent of the population, have diabetes. It occurs when the body does not produce or use insulin, a hormone that is needed to convert sugar required, starches and other food into energy for daily life. Risk factors include inactivity, obesity, physical, unhealthy diet, blood pressure and cholesterol can, history of gestational diabetes and increasing age, many of which are reduced by the movement.
"People assume it's for the continued benefit you, panting, sweating and red face after," said Roberts. "This May off people, especially older adults. However, we found that activities such as Tai Chi can be equally beneficial to improve health. " Tai Chi is an ancient Chinese martial art combines deep breathing and relaxation with slow, circular movements. This low-impact exercise will be changes in posture and develop, in coordination with arm movements.
Sixty-two participants, most Korean women who participated in the study. Half of the group at least 80 percent of the two sessions of one hour per week with three days of practice at home for six months, and the other half served as controls. These meetings had completed a significant improvement in glycemic control and reported higher vitality and energy.
"Those who have participated in sessions of tai chi actually lower blood sugar levels after three and six months," says Roberts. "They also had lower hemoglobin A1c, which means that better control of diabetes." In addition, levels of glucose in the blood improved, participants also reported significantly improved mental health. This was very encouraging, especially since people are less depressed in general, more active and independent, "says Roberts.
Tai Chi is also used for people with arthritis and disabilities to increase, thereby reducing the balance, muscle strength and mobility and the risk of falls. It is useful to examine its effects on other conditions, including the elderly, "said Roberts.
"Tai Chi is an excellent alternative for those who want the benefits of exercise on diabetes control, but not finished May physically demanding due to age, condition or injury," said Roberts. "Future studies could investigate whether tai chi could also benefit from diseases such as osteoporosis or heart disease." Since Tai Chi is an exercise that affects many parts of the body and also helps to relax the mind, it is likely to be participants in the exercise, said Paul Lam, a professor at the University of South Wales School of Public Health and Community Medicine and a practicing physician in Sydney, Australia.
"This study shows that Tai Chi can have a significant impact on management and treatment of diabetes - a health policy major and growing challenge for all Western countries," said Lam.
Predicted prevalence of diabetes and the incidence of atrial fibrillation in women
Atrial fibrillation is 44% more often and 38% more likely to develop diabetes, if present in an adult population was - especially among women, according to the recently published.
The researchers examined the prevalence and incidence of atrial fibrillation in patients with diabetes and 17,372 for the same amount by age and sex matched controls without diabetes mellitus type 2 diabetes, in a registration Kaiser Permanente Northwest. The researchers followed the patients without atrial fibrillation for comparison of the incidence of atrial fibrillation, while controlling known risk factors. The data showed that the prevalence of atrial fibrillation was significantly higher in patients with diabetes compared to those without (3.6% vs 2.5%, p <.0001).
During a mean follow-up of 7.2 years, patients with diabetes without initially developed atrial fibrillation with age and sex adjusted rate of 9.1 per 1000 person years compared with 6.6 per 1000 person-years in patients without diabetes.
Diabetes was associated with an increased risk of 26% for atrial fibrillation in women after adjustment for other risk factors (HR = 1.26, 95% CI, 1.08-1.46). Diabetes not a risk factor statistically significant in men.
Males had a higher prevalence of atrial fibrillation in all age groups, regardless of diabetes, but the difference in the prevalence in people with diabetes vs without diabetes was higher among women. Atrial auricle is 30% more common in men aged 65 to 74 years with diabetes (7.9% vs 6.1%, p <.037), while the prevalence of atrial fibrillation was 61% higher than in women with diabetes the same age group (6.1% vs 3.8%, p =. 002).
"These results have potential impact on public health, especially women and emphasized the need for further investigation of the mechanical connection between diabetes and atrial fibrillation," write the researchers.
The researchers examined the prevalence and incidence of atrial fibrillation in patients with diabetes and 17,372 for the same amount by age and sex matched controls without diabetes mellitus type 2 diabetes, in a registration Kaiser Permanente Northwest. The researchers followed the patients without atrial fibrillation for comparison of the incidence of atrial fibrillation, while controlling known risk factors. The data showed that the prevalence of atrial fibrillation was significantly higher in patients with diabetes compared to those without (3.6% vs 2.5%, p <.0001).
During a mean follow-up of 7.2 years, patients with diabetes without initially developed atrial fibrillation with age and sex adjusted rate of 9.1 per 1000 person years compared with 6.6 per 1000 person-years in patients without diabetes.
Diabetes was associated with an increased risk of 26% for atrial fibrillation in women after adjustment for other risk factors (HR = 1.26, 95% CI, 1.08-1.46). Diabetes not a risk factor statistically significant in men.
Males had a higher prevalence of atrial fibrillation in all age groups, regardless of diabetes, but the difference in the prevalence in people with diabetes vs without diabetes was higher among women. Atrial auricle is 30% more common in men aged 65 to 74 years with diabetes (7.9% vs 6.1%, p <.037), while the prevalence of atrial fibrillation was 61% higher than in women with diabetes the same age group (6.1% vs 3.8%, p =. 002).
"These results have potential impact on public health, especially women and emphasized the need for further investigation of the mechanical connection between diabetes and atrial fibrillation," write the researchers.
Diabetes drug may increase risk for fracture
Patients who take medication for diabetes as the thiazolidinediones may be at greater risk of bone fractures, a new study announced.
In the study, Dr. Ian Douglas of the London School of Hygiene and Tropical Medicine and colleagues have a database of more than 6 million patients in the United Kingdom and found 1819 persons aged 40 and older who had a broken bone and was a kind prescribed thiazolidinedione. The drug was introduced in the 1990s and are used to treat type 2 diabetes.
According to the revised figures to the fact that older people tend to wear broken bones, into account, the researchers found that people taking thiazolidinediones, almost 1.5 times as many fractures were at the use of drugs as if they are not taking drugs . This risk increases the longer people took the drug.
The results confirm previous research that a link between these drugs and bone fractures is recommended. But the researchers acknowledge that the study did not follow the golden rule of research that randomly assign people taking or not taking place.
But Douglas and his colleagues concluded that the results "must be in the broader debate about the risks and potential benefits of therapy should be considered with thiazolidinediones.
In the study, Dr. Ian Douglas of the London School of Hygiene and Tropical Medicine and colleagues have a database of more than 6 million patients in the United Kingdom and found 1819 persons aged 40 and older who had a broken bone and was a kind prescribed thiazolidinedione. The drug was introduced in the 1990s and are used to treat type 2 diabetes.
According to the revised figures to the fact that older people tend to wear broken bones, into account, the researchers found that people taking thiazolidinediones, almost 1.5 times as many fractures were at the use of drugs as if they are not taking drugs . This risk increases the longer people took the drug.
The results confirm previous research that a link between these drugs and bone fractures is recommended. But the researchers acknowledge that the study did not follow the golden rule of research that randomly assign people taking or not taking place.
But Douglas and his colleagues concluded that the results "must be in the broader debate about the risks and potential benefits of therapy should be considered with thiazolidinediones.
Subscribe to:
Posts (Atom)